Merck
CN
  • Column liquid chromatographic determination of bupivacaine in human serum using solid-phase extraction.

Column liquid chromatographic determination of bupivacaine in human serum using solid-phase extraction.

Journal of chromatography. B, Biomedical applications (1994-08-05)
R N Gupta, A Dauphin
ABSTRACT

A convenient and economical procedure for the extraction of bupivacaine and its major metabolites, desbutylbupivacaine and 4'-hydroxybupivacaine, from serum is described. A 0.25-ml aliquot of 4 micrograms/ml solution of N-pentyl-2,6-pipecoloxylidide used as the internal standard and an equal volume of the serum sample are applied to a 1-ml BondElut C18 silica extraction column which has been conditioned by subsequent washing once with 1 M HCl, twice with methanol and once with water. After passing the sample at a slow rate, the column is washed twice with water and once with acetonitrile. The desired compounds are then eluted with a 0.25-ml aliquot of a mixture of 35% perchloric acid-methanol (1:40, v/v). A 5-microliters aliquot of the eluate is injected onto a 150 x 4.6 mm I.D. column packed with 5-microns C8 silica particles, which is eluted at ambient temperature with a mobile phase of acetonitrile-10 mM KH2PO4 (25:80, v/v) at a flow-rate of 1.5 ml/min. The peaks are detected at 205 nm. The extraction recovery of all the compounds is in the range of 90%. The chromatogram is clean and the desired peaks are well separated from each other and from the extraneous peaks.

MATERIALS
Product Number
Brand
Product Description

Mepivacaine impurity B, European Pharmacopoeia (EP) Reference Standard